The GI Effects Microbial Ecology Profile is the most comprehensive stool test that assesses the diverse gut microbiome. Results provide immediate, actionable clinical information for the management of detectable parasites, bacteria, and yeast, as well as providing valuable assessment of gut microbiota via 24 Commensal Bacteria targets.
The GI Effects Microbial Ecology Profile is part of the larger GI Effects Comprehensive Stool Profile, which also provides information about digestion, inflammation, and bacterial metabolism markers. A larger faecal biomarker panel such as the GI Effects Comprehensive Stool Profile offers the advantage of assessing multiple functional areas that may be contributing to symptoms. For example, diarrhea could stem from multiple causes including pancreatic exocrine insufficiency, inflammation, food allergies, or the presence of a pathogenic or potentially pathogenic organism.
Genova Diagnostics is excited to announce the addition of polymerase chain reaction (PCR) for parasites to the GI Effects Profiles. PCR is a highly sensitive and specific methodology that detects an organism's DNA.
The GI Effects now includes 6 PCR targets that detect common protozoan parasites:
The 6 PCR targets replace the 3 EIA biomarkers. The GI Effects upgrade also includes several report enhancements for ease of use.
Learn more about Genova's Comprehensive GI Testing Value.
Patients with a clinical history suggestive of a gastrointestinal infection or dysbiosis can be evaluated with the GI Effects Microbial Ecology Profile. Symptoms such as gas, bloating, abdominal pain, diarrhea, and constipation may be a result of a microbial imbalance or infection. This profile can also be used to monitor treatment efficacy to eradicate an organism or to monitor changes to the microbiota.
Gut microbes are codependent with one another and with their human host, and the health of one affects the other. A sizeable volume of research associates a dysbiotic, or imbalanced gut microbiome with multiple disease states both within and outside of the GI tract.1,2 The microbiome's diverse metabolic activities ultimately impact the human host, and the human hosts activities ultimately affect the microbiome's health.
GI Effects® represents the best technical available to assess the gut microbiome, combining:
The test report is organised so that the clinician can move through results in a logical order that enhances clinical utility, starting with the innovative Interpretation-At-A-Glance pages to synthesise the information.
The GI Effects Microbial Ecology Profile results provide insight into the root cause(s) of gut symptoms originating from a disturbed gut microbiome. Symptoms often improve as identified imbalances become normalised through targeted antimicrobial, dietary, lifestyle, and supplementation therapeutics.
The GI Effects Interpretive Guide is a convenient tool to support the therapeutic decision-making process for patients with complex gut-related conditions.
Test Type: Stool Test
Analyte List |
---|
Akkermansia muciniphila |
Anaerotruncus colihominis |
Bacteriology |
Bacteroides vulgatus |
Bacteroides-Prevotella group |
Barnesiella spp. |
Bifidobacterium longum |
Bifidobacterium spp. |
Butyrivibrio crossotus |
Clostridium spp. |
Collinsella aerofaciens |
Color |
Consistency |
Coprococcus eutactus |
Desulfovibrio piger |
Escherichia coli |
Faecalibacterium prausnitzii |
Fecal Occult Blood |
Firmicutes/Bacteroidetes (F/B Ratio) |
Fusobacterium spp. |
Lactobacillus spp. |
Methanobrevibacter smithii |
Mic Sensitivities, Yeast or Bacteria |
Microscopic Exam Results |
Mycology (Yeast/Fungi) |
Odoribacter spp. |
Other Biomarkers |
Oxalobacter formigenes |
Parasitology |
Parasitology EIA Tests |
Prevotella spp. |
Pseudoflavonifractor spp. |
Roseburia spp. |
Ruminococcus spp. |
Veillonella spp. |
Specimen Requirements |
---|